GlaxoSmithKline Pharmaceuticals Ltd.
Quarter 3 results will be announced on 09 Feb, 2026.
View
ShareGLAXO Share price chart
*Stock prices shown are delayed by 5 minutes
Key Indicators
Data as per latest reports and statements
| Today's low/high | ₹2,331.90 / ₹2,442.90 |
| 52-week low/high | ₹1,921.00 / ₹3,515.70 |
| Circuit range | ₹1,947.36 / ₹2,921.04 |
| Market cap | ₹41,237 Cr |
| PE ratio (TTM) | 44.33 |
| Sector PE | 38.41 |
| ROE | 49.63% |
| ROCE | 67.23% |
| Basic EPS (TTM) | ₹54.91 |
| Diluted EPS | ₹54.76 |
| Book Value per share | ₹115.19 |
| Face Value per share | ₹10 |
| PB ratio | 21.13 |
| Debt to equity | - |
| Dividend Yield | 2.22% |
| EBITDA Margin (TTM) | 36.15% |
Returns calculator
- Total investment₹10,000
- Profit+ ₹1,435
- Dividends+ ₹210
- Total corpus₹11,645
- Absolute returns16.45%
Financials
FY 25- Metric
- Value
- YoY growth
- Operating Revenue
₹3,749 Cr
- EBITDA
₹1,323 Cr
- Profit Before Tax
₹1,260 Cr
- Profit After Tax
₹927.58 Cr
About GlaxoSmithKline Pharmaceuticals Ltd.
Business Verticals & Subsidiaries
- Biddle Sawyer Ltd.
GlaxoSmithKline Pharmaceuticals Ltd. Stock Market Performance
- Nifty Midcap 150
- Nifty 500
- Nifty LargeMidcap 250
- S&P BSE Healthcare
- S&P BSE Dollex - 200
The Latest Details of GLAXO Earnings
The Latest Updates on GLAXO Share Price
GlaxoSmithKline Pharmaceuticals Ltd.'s Board of Directors
| Name | Position |
|---|---|
| Ms. R S Karnad | Chairperson |
| Mr. B Akshikar | Managing Director |
| Mr. J Chandy | WholeTime Director & CFO |
GLAXO Shares FAQs
GlaxoSmithKline Pharmaceuticals Ltd.'s total assets as of 31 Mar 2025 stood at Rs.4,108 Cr.
GlaxoSmithKline Pharmaceuticals Ltd.'s share price as of 28 Jan 2026 is Rs.2,434.20. Over the past 1 month, GlaxoSmithKline Pharmaceuticals Ltd.'s share price has decreased by 6.12%.
The market cap of GlaxoSmithKline Pharmaceuticals Ltd. stood at Rs.41,237 Cr as of 28 Jan 2026.
GLAXO GROUP LIMITED:Holds a stake of 35.99%
GLAXOSMITHKLINE PTE LIMITED:Holds a stake of 28.1%
ESKAYLAB LIMITED:Holds a stake of 6.94%
The PE ratio of GlaxoSmithKline Pharmaceuticals Ltd. is 44.33, and the PB ratio is 21.13.
GlaxoSmithKline Pharmaceuticals Ltd. was established in 1924.
To analyze GlaxoSmithKline Pharmaceuticals Ltd. stock, start by researching the company's financial health, including its revenue, profit margins, debt levels, and cash flow. Look into industry trends, competition, and any recent news or developments that might impact GlaxoSmithKline Pharmaceuticals Ltd..
The 52-week low for GlaxoSmithKline Pharmaceuticals Ltd.'s share price was Rs.1,921.00 and the 52-week high was Rs.3,515.70.
28 Jan 2026 Stock Performance for GlaxoSmithKline Pharmaceuticals Ltd.
On Wednesday, 28 Jan 2026, GlaxoSmithKline Pharmaceuticals Ltd.'s stocks opened at Rs.2,351 and closed at Rs.2,434.20. The day's trading saw the stock reach a high of Rs.2,442.90 and a low of Rs.2,331.90.
GlaxoSmithKline Pharmaceuticals Ltd. is listed on NSE. It is also listed on BSE.
